Literature DB >> 18508613

Papillomavirus 3' UTR regulatory elements.

Sheila V Graham1.   

Abstract

Papillomaviruses infect epithelial cells causing mainly benign lesions or warts. In some rare instances, these may progress to malignancy. For example, human papillomavirus type 16 (HPV16) is the causative agent of 60 percent of cases of cervical cancer. The replication cycle of papillomaviruses is intimately linked to epithelial differentiation. In particular, late gene expression is completed exclusively in the upper epithelial layers. Regulation of late gene expression is largely by post-transcriptional means. RNAs encoding the late proteins, the virus capsid proteins L1 and L2, can be detected in the lower layers of infected epithelia but protein is detected only in the upper layers. It is clear that cellular factors mediate this gene regulation. RNA regulatory elements that bind RNA processing factors that mediate post-transcriptional control have been identified in the 3' untranslated regions of a number of papillomaviruses. These elements, the proteins they bind and the mechanisms by which they are proposed to act are discussed. Further understanding of such host-virus molecular interactions may lead to development of novel strategies for abrogating virus infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508613     DOI: 10.2741/3107

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  17 in total

1.  Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing.

Authors:  Soniya Dhanjal; Naoko Kajitani; Jacob Glahder; Ann-Kristin Mossberg; Cecilia Johansson; Stefan Schwartz
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

2.  Construction of a full transcription map of human papillomavirus type 18 during productive viral infection.

Authors:  Xiaohong Wang; Craig Meyers; Hsu-Kun Wang; Louise T Chow; Zhi-Ming Zheng
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

3.  Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome.

Authors:  Monika Somberg; Stefan Schwartz
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

Review 4.  Regulation of human papillomavirus gene expression by splicing and polyadenylation.

Authors:  Cecilia Johansson; Stefan Schwartz
Journal:  Nat Rev Microbiol       Date:  2013-03-11       Impact factor: 60.633

5.  Analysis of transcripts from predicted open reading frames of Musca domestica salivary gland hypertrophy virus.

Authors:  Tamer Z Salem; Alejandra Garcia-Maruniak; Verena-U Lietze; James E Maruniak; Drion G Boucias
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

6.  Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes.

Authors:  T Klymenko; H Hernandez-Lopez; A I MacDonald; J M Bodily; S V Graham
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

7.  Intron definition and a branch site adenosine at nt 385 control RNA splicing of HPV16 E6*I and E7 expression.

Authors:  Masahiko Ajiro; Rong Jia; Lifang Zhang; Xuefeng Liu; Zhi-Ming Zheng
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

Review 8.  RNA Binding Proteins that Control Human Papillomavirus Gene Expression.

Authors:  Naoko Kajitani; Stefan Schwartz
Journal:  Biomolecules       Date:  2015-05-05

9.  Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF.

Authors:  Sarah Mole; Steven G Milligan; Sheila V Graham
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

10.  The RNA stability regulator HuR regulates L1 protein expression in vivo in differentiating cervical epithelial cells.

Authors:  S A Cumming; T Chuen-Im; J Zhang; S V Graham
Journal:  Virology       Date:  2008-11-04       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.